Brain surgery trial tests new drug to help stroke survivors move again
Disease control
Not yet recruiting
This is the first study in people to test a new drug called ASP2246. It aims to see if it is safe and can help improve movement in adults who still have trouble moving an arm or leg several months after a stroke. The drug is delivered directly into the damaged area of the brain d…
Phase: PHASE1, PHASE2 • Sponsor: Astellas Pharma Inc • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC